Last Updated: 31-07-2025 | Format: PDF | Report ID:20385 | Author: Abhishek
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $4,250 Million |
| What is the projected market size by 2035? | $10,500 Million |
| What is the market CAGR from 2025 to 2035? | 9.5% |
| Which region dominates the market? | United States (74%) |
| Which product/service type dominates the market? | Serum-free Media (34%) |
| Which application leads the market? | Biopharmaceutical Production (40%) |
| Who are the major buyers? | Pharma & Biotech Companies (53%), Academic/Research Institutes (28%) |
| What are the key market growth drivers? | Surge in biopharmaceutical production and personalized medicine pipelines; Rising demand for advanced cell culture solutions in cancer research |
| What are the major market challenges? | Ensuring consistent supply chain reliability amidst global raw material fluctuations; Stringent regulatory requirements and validation costs |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? |
| Thermo Fisher Scientific, Merck KGaA, Cytiva (Danaher Corporation), Lonza Group AG, Corning Incorporated, FUJIFILM Irvine Scientific, Sartorius AG, Becton Dickinson, HiMedia Laboratories, PromoCell GmbH, STEMCELL Technologies, Takara Bio Inc., GE Healthcare, Miltenyi Biotec, CellGenix GmbH |
Global Stem Cell Therapy Market Market: by Type (Allogeneic, Autologous), Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other Applications), Distribution Channels (Hospitals, Clinics, Academic & Research Institutes, Contract Research Organizations, Direct Sales, Online Channels), Technology (Stem Cell Acquisition, Stem Cell Preservation, Expansion, Sub-culture, Cryopreservation, Other Technologies), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Single Use Bioprocessing Market: by Type (Single-Use Bioreactors, Disposable Mixers, Filtration Devices, Bags & Containers, Tubing, Sampling Systems), Application (Filtration, Cell Culture, Mixing, Storage, Purification, Sampling), Distribution Channels (Direct Sales, Distributors, Online, Retail, Third-Party Vendors, Others), Technology (Stirred-tank, Wave-induced, Centrifugal, Hybrid, Flow-through, Microcarrier-based) Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Cell & Gene Therapy Manufacturing Services Market: by Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others), Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others), Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Others), Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025